Abstract: To design the “Kansei value” aspect of a product, it is useful to design multilayered relationships of perceptual and affective responses via the physical or psychophysical properties of the ...
Abstract: The Steelmaking-Continuous Casting (SCC) scheduling problem is usually regarded as a type of hybrid flow-shop scheduling problems (HFSP) with special process constraints. To research the SCC ...
Maintainers and developers are now using AI to help build Linux. Simultaneously, Rust has graduated to being a co-equal language with C for mainstream Linux development. However, the programming world ...
Sorting algorithms are a common exercise for new programmers, and for good reason: they introduce many programming ...
Abstract: The flush air data sensing (FADS) system resolves air data state issues through redundant measurements of surface pressure distributions on the vehicle, with its fault-tolerant algorithm ...
Abstract: In the realm of healthcare, the integration of Internet of Things (IoT) technology has revolutionized patient monitoring, allowing for real-time data collection and analysis. This abstract ...
Abstract: The extensive adoption of cloud computing platforms in storing and processing data have brought forth a new age of efficiency in the way data is stored, processed and managed, requiring new ...
Strengthen your skills in skills in data collection, exploration, analysis, visualization, presentation and dissemination as a student in our flexible, fully online bachelor's degree in data analytics ...
Abstract: This letter presents Open-Structure, a novel benchmark dataset for evaluating visual odometry and SLAM methods. Compared to existing public datasets that primarily offer raw images, ...
Abstract: With the rapid progression of communication and localisation of big data over billions of devices, distributed Machine Learning (ML) techniques are emerging to cater for the development of ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results